HRP20110189T1 - Karbonilamino derivati korisni za liječenje upalne bolesti crijeva - Google Patents

Karbonilamino derivati korisni za liječenje upalne bolesti crijeva Download PDF

Info

Publication number
HRP20110189T1
HRP20110189T1 HR20110189T HRP20110189T HRP20110189T1 HR P20110189 T1 HRP20110189 T1 HR P20110189T1 HR 20110189 T HR20110189 T HR 20110189T HR P20110189 T HRP20110189 T HR P20110189T HR P20110189 T1 HRP20110189 T1 HR P20110189T1
Authority
HR
Croatia
Prior art keywords
treatment
inflammatory bowel
bowel disease
derivatives useful
carbonylamino derivatives
Prior art date
Application number
HR20110189T
Other languages
English (en)
Inventor
Siim Madsen Lars
Christophersen Palle
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of HRP20110189T1 publication Critical patent/HRP20110189T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Uporaba 2,2-bis-(4-fluoro-fenil)-3-metil-butiramida, ili farmaceutski prihvatljivog dodatka soli ovoga, naznačena time, što je za proizvodnju lijeka za liječenje, prevenciju ili ublažavanje upalnih bolesti crijeva.

Claims (1)

1. Uporaba 2,2-bis-(4-fluoro-fenil)-3-metil-butiramida, ili farmaceutski prihvatljivog dodatka soli ovoga, naznačena time, što je za proizvodnju lijeka za liječenje, prevenciju ili ublažavanje upalnih bolesti crijeva.
HR20110189T 2007-08-24 2011-03-15 Karbonilamino derivati korisni za liječenje upalne bolesti crijeva HRP20110189T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95781107P 2007-08-24 2007-08-24
DKPA200701211 2007-08-24
PCT/EP2008/060910 WO2009027292A1 (en) 2007-08-24 2008-08-21 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders

Publications (1)

Publication Number Publication Date
HRP20110189T1 true HRP20110189T1 (hr) 2011-04-30

Family

ID=39870538

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110189T HRP20110189T1 (hr) 2007-08-24 2011-03-15 Karbonilamino derivati korisni za liječenje upalne bolesti crijeva

Country Status (11)

Country Link
US (1) US8455549B2 (hr)
EP (2) EP2322164A3 (hr)
JP (1) JP2010536827A (hr)
AT (1) ATE494891T1 (hr)
DE (1) DE602008004563D1 (hr)
DK (1) DK2192896T3 (hr)
ES (1) ES2358564T3 (hr)
HR (1) HRP20110189T1 (hr)
PL (1) PL2192896T3 (hr)
PT (1) PT2192896E (hr)
WO (1) WO2009027292A1 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010053584A2 (en) 2008-11-10 2010-05-14 Boehringer Ingelheim International Gmbh Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
US10179115B2 (en) 2015-02-20 2019-01-15 The Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
WO2018081018A1 (en) * 2016-10-25 2018-05-03 Paracelsus Neuroscience Llc Use of senicapoc for treatment of neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0918514B9 (en) 1996-03-20 2006-07-05 President And Fellows Of Harvard College Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
US5889038A (en) 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
US6288122B1 (en) 1999-02-23 2001-09-11 Icagen, Inc. Gardos channel antagonists
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US6803375B1 (en) 2000-01-06 2004-10-12 The Regents Of The University Of California Non-peptide inhibition of T-lymphocyte activation and therapies related thereto
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
AU2003201273A1 (en) 2002-01-04 2003-07-30 Poseidon Pharmaceuticals A/S Potassium channel modulators
US7129618B2 (en) * 2003-03-31 2006-10-31 Canon Kabushiki Kaisha Control apparatus capable of low-speed driving of vibration type driving apparatus, actuating apparatus using the control apparatus, control method capable of low-speed driving of vibration type driving apparatus, and storage medium storing program including program codes capable of realizing the control method
GB0414272D0 (en) * 2004-06-25 2004-07-28 Cellpep Sa OsK1 derivatives
KR20080086511A (ko) * 2005-12-20 2008-09-25 이카겐, 인코포레이티드 트리아릴 메탄 화합물을 이용한 치료 방법

Also Published As

Publication number Publication date
DK2192896T3 (da) 2011-04-04
WO2009027292A1 (en) 2009-03-05
US20110124735A1 (en) 2011-05-26
EP2322164A2 (en) 2011-05-18
EP2192896B1 (en) 2011-01-12
US8455549B2 (en) 2013-06-04
PL2192896T3 (pl) 2011-06-30
EP2192896A1 (en) 2010-06-09
ES2358564T3 (es) 2011-05-11
ATE494891T1 (de) 2011-01-15
DE602008004563D1 (de) 2011-02-24
EP2322164A3 (en) 2011-12-07
PT2192896E (pt) 2011-04-04
JP2010536827A (ja) 2010-12-02

Similar Documents

Publication Publication Date Title
EA200900178A1 (ru) Конденсированные гетероциклические производные и их применение
ECSP10010156A (es) Piperidino-dihidrotienopirimidinas sustituidas
EA200702200A1 (ru) Дигидротиенопиримидины для лечения воспалительных заболеваний
ATE517882T1 (de) Chinolinderivate
EP3252057A3 (en) Multicyclic compounds and methods of use thereof
MY177111A (en) Substituted amide derivatives and methods of use
DK2150530T3 (da) Substituerede sulfonamid-derivater
WO2008079291A3 (en) Substituted heterocycles and methods of use
TW200631583A (en) Substituted pteridines for the treatment of inflammatory diseases
IL180979A (en) Isoindulin compounds and their use
GT200500060A (es) Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos
EA200801998A1 (ru) ПИРИДИН[3,4-b]ПИРАЗИНОНЫ
TW200728307A (en) Novel spirochromanone derivatives
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
EA201400392A1 (ru) ПРОИЗВОДНЫЕ 6-ЗАМЕЩЕННЫХ ТРИАЗОЛОПИРИДАЗИНОВ КАК АГОНИСТЫ Rev-Erb
ATE549338T1 (de) Substituierte pteridine, die mit einem viergliedrigen heterocyclus substituiert sind
ATE440834T1 (de) Substituierte arylaminderivate und verwendungsverfahren
WO2008086014A3 (en) Bis-aryl amide derivatives useful for the treatment of cancer
WO2006058869A8 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
WO2014106238A8 (en) Heterocyclic compounds and methods of use thereof
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
TW200633711A (en) Substituted pteridines for the treatment of inflammatory diseases
WO2007131907A3 (en) 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
HRP20110189T1 (hr) Karbonilamino derivati korisni za liječenje upalne bolesti crijeva